PAZOPANIB HCL

Formula & Concentration

PAZOPANIB HCL – pazopanib 200 mg tablet

Manufacturer

Apotex Corp*

*Supplied through partnership with Capital Wholesale Co.

Indications

Renal cell carcinoma; soft or connective tissue sarcoma

Product Options

Package Size

NDC #

Presentation

200 mg

60505-4779-07

Tablet

Shelf Life and Storage

Controlled Room Temp (20-25°C)